Clicky

Evogene(EVGN)

Description: Evogene Ltd., a plant genomics company, engages in the development of enhanced plant traits through the use of plant genomics. It primarily focuses on the development of food crops, including corn, soybean, cotton, canola, rice, and wheat, as well as castor for the production of biofuel. The company's technologies include ATHLETE for gene discovery; Gene2Product for enhancing trait efficacy and probability of successful development of biotechnology seed products; and EvoBreed for breeding enhancement. It holds granted or pending patents to approximately 3,000 novel genes. The company has collaboration agreements with Bayer CropScience; Biogemma; Centre de Cooperation Internationale en Recherche Agronomique pour le Development; DuPont; Monsanto Company; Rahan Meristem (1998) LTD; Rasi Seeds (P) Ltd.; Syngenta; Vilmorin; Viterra; and Zeraim Gedera for the development of various products and provision of plant enhancement solutions. Evogene Ltd. was founded in 1999 and is headquartered in Rehovot, Israel.


Keywords: Biotechnology Crops Biofuel Cotton Soybean Genomics Wheat Canola Oil Monsanto Rehovot Food Crops Seed Products Seed Companies Syngenta Evogene Vilmorin

Home Page: www.evogene.com

EVGN Technical Analysis

13 Gad Feinstein Street
Rehovot, 7414002
Israel
Phone: 972 8 931 1900


Officers

Name Title
Mr. Ofer Haviv CPA CEO & Pres
Mr. Mark Kapel Chief Technology Officer
Dr. Elran Hillel Haber M.B.A., Ph.D. Chief Exec. Officer of Biomica Ltd
Mr. Yaron Eldad Chief Financial Officer
Dr. Eyal Emmanuel Chief Scientific Officer
Mr. Sassi Masliah Exec. VP of Corp. Devel.
Ms. Liat Foigel Wejgman VP of HR
Dr. Nir Arbel Chief Product Officer
Mr. Dotan Borenstein Chief Bus. Officer of Lavie Bio Ltd.
Mr. Eyal Ronen Exec. VP of Bus. Devel.

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 0.9638
Price-to-Sales TTM: 21.988
IPO Date: 2008-03-05
Fiscal Year End: December
Full Time Employees: 133
Back to stocks